Probucol modulates iron nitrilotriacetate (Fe-NTA)-dependent renal carcinogenesis and hyperproliferative response: Diminution of oxidative stress

Molecular and Cellular Biochemistry

Volumn 304, Issue 1-2, 2007, Pages 61-69

  Iqbal, Mohammad ^a   Okazaki, Yasumasa ^b   Okada, Shigeru ^b  

^a UNIVERSITI MALAYSIA SABAH   (Malaysia)

^b OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Antioxidant enzymes; Carcinogenesis; Chemoprevention; Iron nitrilotriacetate; Oxidative stress; Probucol; Tumor promotion

Indexed keywords

DIETHYLNITROSAMINE; GLUTATHIONE; HYPOCHOLESTEROLEMIC AGENT; NITRILOTRIACETATE IRON; ORNITHINE DECARBOXYLASE; PROBUCOL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (QUINONE); REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER INCIDENCE; CARCINOGENESIS; CELL PROLIFERATION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG ACTIVITY; DRUG MECHANISM; ENZYME ACTIVITY; HISTOPATHOLOGY; KIDNEY TUMOR; LIPID PEROXIDATION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTIOXIDANTS; CARCINOGENS; CELL PROLIFERATION; DRUG EVALUATION, PRECLINICAL; FERRIC COMPOUNDS; KIDNEY NEOPLASMS; MALE; MICE; MICE, INBRED STRAINS; NITRILOTRIACETIC ACID; OXIDATIVE STRESS; PROBUCOL;

ANIMALIA;

EID: 34648814030     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-007-9486-6     Document Type: Article

References (46)

1. Cancer facts and figures (1997) American Cancer Society, Inc
2. Birt DF, Pelling JC, Nair S et al (1996) Diet intervention for modifying cancer risk. Prog Clin Biol Res 395:223-234
3. Morse MA, Stoner GD (1993) Cancer chemoprevention: Principles and prospects. Carcinogenesis 14:1737-1746
4. Okada S, Midorikawa O (1982) Induction of rat renal adenocarcinoma by ferric nitrilotriacetate. Jpn Arch Int Med 29:485-491
5. Mizuno R, Kawabata T, Sutoh Y et al (2006) Oxidative renal tubular injuries induced by aminocarboxylate-type iron (III) coordination compounds as candidate renal carcinogens. Biometals 19:675-683
6. Awai M, Nagasaki M, Yamanoi Y et al (1979) Induction of diabetes in animals by parenteral administration of ferric nitrilotriacetate. A model of experimental haemochromatosis. Am J Pathol 95:663-672
7. Aruoma OI, Halliwell B, Gajewski E et al (1989) Damage to the bases in DNA induced by hydrogen peroxide and ferric ion chelates. J Biol Chem 24:20509-20512
8. Toyokuni S, Uchida K, Okamoto K et al (1994) Formation of 4-hydroxy-2-nonenal-modified proteins in renal proximal tubules of rats treated with renal carcinogen. Proc Natl Acad Sci USA 91:2616-2620
9. Athar M, Iqbal M (1998) Ferric nitrilotriacetate promotes N -diethyl nitrosoamine-induced renal tumorigenesis in rat: Implications for the involvement of oxidative stress. Carcinogenesis 19:1133-1139
10. Iqbal M, Giri U, Athar M (1995) Ferric nitrilotriacetate is a potent hepatic tumor promoter and acts through the generation of oxidative stress. Biochem Biophys Res Commun 212:557-563
11. Iqbal M, Sharma SD, Rahman A et al (1999) Evidence that ferric nitrilotriacetate mediates oxidative stress by down-regulating DT-diaphorase activity: Implications for carcinogenesis. Cancer Lett 141:151-157
12. Iqbal M, Giri U, Giri DK et al (1997) Evidence that Fe-NTA induced renal prostaglandin F2∝ is responsible for hyperplastic response in kidney implications for the role of cyclooxygenase-dependent arachidonic acid metabolism in renal tumor promotion. Biochem Mol Biol Intl 42:1115-1124
13. Iqbal M, Giri U, Giri DK et al (1999) Age dependent renal accumulation of 4-hydroxy-2-nonenal (HNE)-modified proteins following parenteral administration of ferric nitrilotriacetate commensurate with its differential toxicity: Implications for the involvement of HNE-protein adducts in oxidative stress and carcinogenesis. Arch Biochem Biophys 365:101-112
14. Wissler A, Vesselinovitch D (1983) Combined effects of cholestyramine and probucol on regression of atherosclerosis in Rhesus monkey aortas. Appl Pathol 1:89-96
15. Yamamoto A, Matsuzawa Y, Yokoyama S et al (1986) Effects of probucol on xanthoma regression in familial hypercholesterolemia. Am J Cardiol 57:29H-35H
16. Bridges AB, Scott NA, Belch JJF (1991) Probucol, a superoxide free radical scavenger in vitro. Atherosclerosis 89: 263-265
17. Hiramatsu M, Liu J, Edamatsu R et al (1994) Probucol scavenged 1,1-diphenyl-2-picrylhydrazyl radicals and inhibited formation of thiobarbituric acid reactive substances. Free Radic Biol Med 16:201-206
18. Dujovne AC, Harris WS, Colle Gerrond LL et al (1994) Comparison of effects of probucol versus vitamin E on ex vivo oxidation susceptibility of lipoproteins in hyperlipoproteinemia. Am J Cardiol 74:38-42
19. Gotoh N, Shimizu K, Komuro E et al (1992) Antioxidation activities of probucol against lipid peroxidation. Biochim Biophys Acta 1128:147-154
20. Kuzuya M, Kuzuya F (1993) Probucol as an antioxidant and antiatherogenic drug. Free Radic Biol Med 14:67-77
21. Bird JE, Milhoan K, Wilson CB et al (1988) Ischemic acute renal failure and antioxidant therapy in rat. The relation between glomerular and tubular dysfunction. J Clin Invest 81:1630-1638
22. Dage RC, Anderson BA, Mao SJ et al (1991) Probucol reduced myocardial dysfunction during reperfusion after short-term ischemia in rabbit heart. J Cardiovas Pharmacol 17:158-165
23. Iqbal M, Okada S (2003) Induction of NAD(P)H: quinone reductase by probucol: A possible mechanism for protection against chemical carcinogenesis and toxicity. Pharmacol Toxicol 93:259-263
24. Iqbal M, Sharma SD, Okada S (2004) Probucol as a potent inhibitor of oxygen radical induced lipid peroxidation and DNA damage: In vitro studies. Redox Rep 9:167-172
25. Mohandas J, Marshall JJ, Duggin GG et al (1984) Differential distribution of glutathione and glutathione related enzymes in rabbit kidney: Possible implications in analgesic neuropathy. Cancer Res 44:5086-5091
26. Jollow DJ, Mitchell JR, Zampagilone N et al (1974) Bromobenzene-induced liver necrosis: Protective role of glutathione and evidence for 3,4-bromobenzene oxides as a hepatotoxic intermediate. Pharmacology 11:151-169
27. Buege JA, Aust SD (1978) Microsomal lipid peroxidation. In: Packer L (ed) Methods in enzymology, vol 52, Academic Press, NJ, pp 302-310
28. O'Brien TG, Simsiman RC, Boutwell RK (1975) Induction of the polyamine biosynthetic enzymes in mouse epidermis by tumor promoting agents. Cancer Res 35:1662-1670
29. Zaheer N, Tiwari KK, Krishnan PS (1965) Exposure and solubilization of hepatic mitochondrial shunt dehydrogenase. Arch Biochem Biophys 109:646-648
30. Carlberg I, Mannervik B (1975) Glutathione reductase levels in rat brain. J Biol Chem 250:5475-5480
31. Claiborne A (1985) Catalase activity. In: Green Wald RA (ed) CRC handbook of methods for oxygen radical research. CRC Press, Boca Raton, FL, pp 283-284
32. Habig WH, Pabst MJ, Jokoby WB (1974) Glutathione S-transferase: The first enzymatic step in mercapturic acid formation. J Biol Chem 249:7130-7139
33. Benson AM, Hunkeler AJ, Talalay P (1980) Increase of NADPH: Quinone reductase activity by dietary antioxidants: Possible role in protection against carcinogenesis and toxicity. Proc Natl Acad Sci USA 77:5216-5220
34. Agarwal R, Mukhtar H (1991) Cutaneous chemical carcinogenesis. In: Mukhtar H (ed) Pharmacology of skin. CRC Press, Boca Raton, FL, pp 371-387
35. DiGiovanni J (1992) Multistage carcinogenesis in mouse skin. Pharmacol Ther 54:63-128
36. Ames BN, Gold LS, Willett WC (1995) The cause and prevention of cancer. Proc Natl Acad Sci USA 92:5258-5265
37. Cerutti PA (1994) Oxy-radicals and cancer. Lancet 344:862-863
38. Kensler TW, Taffe BG (1989) Role of free radicals in tumor promotion and progression. Prog Clin Biol Res 298:233-248
39. Perchellet JP, Perchellet EM (1989) Antioxidants and multistage carcinogenesis in mouse skin. Free Radic Biol Med 7:377-408
40. El-Demerdash E, El-Denshary E, El-Didi M (2002) Probucol and liver efficiency during chemically-induced hepatocarcinogenesis. Anticancer Res 22:977-984
41. Zarkovic M, Qin X, Nakatsuru Y et al (1995) Inhibitory effect of probucol on benzo[a]pyrene induced lung tumorigenesis. Carcinogenesis 16:2599-2601
42. Nishimura G, Yanoma S, Mizuno H et al (1999) An antioxidant, probucol, induces anti-angiogenesis and apoptosis in athymic nude mouse xenografted human head and neck squamous carcinoma cells. Jpn J Cancer Res 90:1224-1230
43. Cohen SM, Ellwin LB (1990) Cell proliferation and carcinogenesis. Science 249:1007-1011
44. Qin X, Zhang S, Zarkovic M et al (1995) Inhibitory effect of probucol on nephrotoxicity induced by ferric nitrilotriacetate in rats. Carcinogenesis 16:2549-2552
45. Haklar G, Sirikci O, Ozer NK et al (1998) Measurement of reactive oxygen species by chemiluminescence in diet-induced atherosclerosis: Protective roles of vitamin E and probucol on different radical species. Int J Clin Lab Res 28:122-126
46. Ito M, Suzuki Y, Ishibara M (1998) Anti-ulcer effects of antioxidants: Effect of probucol. Eur J Pharmacol 354:189-196